alanyl-alanyl-alanine

RN given refers to all (L)-isomer

Also Known As:

Ala-Ala-Ala; alanyl-alanyl-alanine, (D-Ala-D-Ala-D-Ala)-isomer; alanyl-alanyl-alanine, (L-Ala-D-Ala-L-Ala)-isomer; alanyl-alanyl-alanine, (L-Ala-L-Ala-D-Ala)-isomer; tri-L-alanine; trialanine

Networked: 16 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - alanyl-alanyl-alanine: 16

Experts

1.	Wong, Ruey-Hong: 2 articles (06/2012 - 06/2010)
2.	Kazemi, Elham: 1 article (01/2015)
3.	Moradi, Mohammad-Taher: 1 article (01/2015)
4.	Rahimi, Zohreh: 1 article (01/2015)
5.	Shahbazi, Mehrdad: 1 article (01/2015)
6.	Yari, Kheirollah: 1 article (01/2015)
7.	Hu, Wanning: 1 article (10/2012)
8.	Liu, Geling: 1 article (10/2012)
9.	Sun, Guogui: 1 article (10/2012)
10.	Wang, Dan: 1 article (10/2012)

Related Diseases

1.	Granuloma 01/01/1986 - "In this study we detected hydrolytic activities for [3H]-elastin and Suc-Ala-Ala-Ala-pNA (SLAPN) in hepatic granulomas which became elevated in parallel with enlargement of the granulomas and disappearance of aldehyde-fuchsin-stained filaments in the lesions of mice infected with Schistosoma mansoni. "
2.	Breast Neoplasms (Breast Cancer) 01/01/2006 - "We found that the variant genotypes of both ADPRT Val762Ala and XRCC1 Arg399Gln were not significantly associated with the risk of breast cancer (adjusted OR 0.87, 95% CI 0.64 to 1.19 for ADPRT Val/Ala + Ala/Ala; adjusted OR 0.82, 95% CI 0.61 to 1.11 for XRCC1 Arg/Gln + Gln/Gln; and adjusted OR 0.70, 95% CI 0.45 to 1.10 for these two combined variant genotypes. " 10/01/2012 - "Crude odds ratios (ORs) with 95% confidence intervals (CIs) for breast cancer risk associated with co-dominant models [valine/alanine (Val/Ala) vs. Val/Val, Ala/Ala vs. Val/Val], a dominant model (Val/Ala + Ala/Ala vs. Val/Val) and a recessive model (Ala/Ala vs. Val/Ala + Val/Val) were statistically estimated. "
3.	Atherosclerosis 01/01/1983 - "In nonsmokers, the average serum elastase-type activity on succinyl trialanine paranitroanilide was found equal to 78.1 ng/ml porcine pancreatic elastase equivalents and on 3H-kappa-elastin sepharose beads equal to 688.8 ng/ml. No statistically significant differences were observed in elastase levels in the sera of individuals presenting clinical symptoms of atherosclerosis. "
4.	Pulmonary Sarcoidosis 03/01/1990 - "In this cross-sectional study, we measure several phagocyte derived enzymes, namely plasminogen activator, neutrophil elastase and an ill-defined protease active on the trialanine chromophore substrate succinyl-alanine3-nitroanilide (SLAPN) in bronchoalveolar lavage (BAL) fluid from 42 patients with pulmonary sarcoidosis and from 43 patients with collagen vascular disease (CVD), 22 without lung disease (group I) and 21 associated with parenchymal lung disease (group II). "
5.	Vascular Diseases (Vascular Disease) 03/01/1990 - "In this cross-sectional study, we measure several phagocyte derived enzymes, namely plasminogen activator, neutrophil elastase and an ill-defined protease active on the trialanine chromophore substrate succinyl-alanine3-nitroanilide (SLAPN) in bronchoalveolar lavage (BAL) fluid from 42 patients with pulmonary sarcoidosis and from 43 patients with collagen vascular disease (CVD), 22 without lung disease (group I) and 21 associated with parenchymal lung disease (group II). "

Related Drugs and Biologics

1.	succinyl-trialanine-4-nitroanilide (SANA)
2.	Rosaniline Dyes (Fuchsin)
3.	Elastin
4.	Aldehydes
5.	Pancreatic Elastase (Elastase)
6.	Enzymes
7.	valylvaline (Val-Val)
8.	ADP Ribose Transferases (ADP Ribosyltransferase)
9.	Endopeptidase K (Proteinase K)
10.	Leukocyte Elastase (Neutrophil Elastase)